Patents by Inventor Paul D. Hoeprich, Jr.

Paul D. Hoeprich, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11279749
    Abstract: Synthetic apolipoproteins based on native/naturally occurring homolog proteins can be prepared using solid-phase peptide synthesis approaches combined with native chemical ligation methods to create analogs of full length apolipoproteins. The chemical synthesis is expected to allow introduction of non-natural amino acids, e.g., ?,??-dialkyl amino acids, with a periodicity that encourages both helix formation and amphipathicity. Such apolipoprotein analogs are expected to encourage, in some embodiments, facile and more complete NLP formation, enabling consideration of full spectrum of nanoparticle-based biotechnology applications ranging from therapeutic sequestration and delivery to energy/biofuel production to biopolymer production.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: March 22, 2022
    Assignee: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
    Inventors: Paul D. Hoeprich, Jr., Julio A. Camarero
  • Patent number: 10934628
    Abstract: Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators.
    Type: Grant
    Filed: October 22, 2018
    Date of Patent: March 2, 2021
    Assignee: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
    Inventors: Paul D. Hoeprich, Jr., Sangil Kim
  • Publication number: 20190094230
    Abstract: Provided herein are methods and systems for the production of a nanolipoprotein particle (NLP) that includes a scaffold protein a membrane forming lipid and optionally a target protein. At least one of the scaffold protein and target protein can be provided through an IVT system. The membrane forming lipid, scaffold protein and optionally the target protein can be assembled for a time and under conditions that allow obtaining high yield NLPs, NPLs with an increased solubility, an NLP of a controlled size, and/or an NLP having a size predetermined to include a pre-selected target protein.
    Type: Application
    Filed: October 12, 2018
    Publication date: March 28, 2019
    Inventors: Matthew A. COLEMAN, Paul D. HOEPRICH, JR., Brent W. SEGELKE
  • Publication number: 20190055658
    Abstract: Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators.
    Type: Application
    Filed: October 22, 2018
    Publication date: February 21, 2019
    Inventors: Paul D. HOEPRICH, JR., Sangil KIM
  • Patent number: 10151037
    Abstract: Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: December 11, 2018
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Paul D. Hoeprich, Jr., Sangil Kim
  • Publication number: 20180186860
    Abstract: Synthetic apolipoproteins based on native/naturally occurring homolog proteins can be prepared using solid-phase peptide synthesis approaches combined with native chemical ligation methods to create analogs of full length apolipoproteins. The chemical synthesis is expected to allow introduction of non-natural amino acids, e.g., ?,??-dialkyl amino acids, with a periodicity that encourages both helix formation and amphipathicity. Such apolipoprotein analogs are expected to encourage, in some embodiments, facile and more complete NLP formation, enabling consideration of full spectrum of nanoparticle-based biotechnology applications ranging from therapeutic sequestration and delivery to energy/biofuel production to biopolymer production.
    Type: Application
    Filed: September 9, 2016
    Publication date: July 5, 2018
    Inventors: Paul D. HOEPRICH, JR., Julio A. CAMARERO
  • Patent number: 9688718
    Abstract: Provided herein are nanolipoprotein particles that comprise a membrane associated hydrogenase and related assemblies, devices, methods and systems.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: June 27, 2017
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Sarah E. Baker, Brett A. Chromy, Paul Henderson, Paul D. Hoeprich, Jr.
  • Patent number: 9458191
    Abstract: Provided herein are methods and systems for assembling, solubilizing and/or purifying a membrane associated protein in a nanolipoprotein particle, which comprise a temperature transition cycle performed in presence of a detergent, wherein during the temperature transition cycle the nanolipoprotein components are brought to a temperature above and below the gel to liquid crystalling transition temperature of the membrane forming lipid of the nanolipoprotein particle.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: October 4, 2016
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Brett A. Chromy, Paul Henderson, Paul D. Hoeprich, Jr.
  • Publication number: 20160083858
    Abstract: Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators.
    Type: Application
    Filed: September 22, 2015
    Publication date: March 24, 2016
    Inventors: Paul D. HOEPRICH, Jr., Sangil KIM
  • Publication number: 20150105538
    Abstract: Provided herein are methods and systems for assembling, solubilizing and/or purifying a membrane associated protein in a nanolipoprotein particle, which comprise a temperature transition cycle performed in presence of a detergent, wherein during the temperature transition cycle the nanolipoprotein components are brought to a temperature above and below the gel to liquid crystalling transition temperature of the membrane forming lipid of the nanolipoprotein particle.
    Type: Application
    Filed: November 7, 2014
    Publication date: April 16, 2015
    Inventors: Brett A. CHROMY, Paul HENDERSON, Paul D. HOEPRICH, JR.
  • Patent number: 8907061
    Abstract: Provided herein are methods and systems for assembling, solubilizing and/or purifying a membrane associated protein in a nanolipoprotein particle, which comprise a temperature transition cycle performed in presence of a detergent, wherein during the temperature transition cycle the nanolipoprotein components are brought to a temperature above and below the gel to liquid crystalling transition temperature of the membrane forming lipid of the nanolipoprotein particle.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: December 9, 2014
    Assignee: Lawrence Livermore National Security, LLC.
    Inventors: Brett A. Chromy, Paul Henderson, Paul D. Hoeprich, Jr.
  • Publication number: 20090203549
    Abstract: A functionalized platform for a polymer array, comprising a substrate, and a metal oxide layer that attaches a functionalized alkyl phosphonate compound is described together with related array methods and systems.
    Type: Application
    Filed: February 5, 2009
    Publication date: August 13, 2009
    Inventor: Paul D. HOEPRICH, JR.
  • Publication number: 20090192299
    Abstract: Provided herein are methods and systems for assembling, solubilizing and/or purifying a membrane associated protein in a nanolipoprotein particle, which comprise a temperature transition cycle performed in presence of a detergent, wherein during the temperature transition cycle the nanolipoprotein components are brought to a temperature above and below the gel to liquid crystalling transition temperature of the membrane forming lipid of the nanolipoprotein particle.
    Type: Application
    Filed: January 12, 2009
    Publication date: July 30, 2009
    Inventors: Brett A. CHROMY, Paul Henderson, Paul D. Hoeprich, JR.
  • Publication number: 20090186393
    Abstract: Provided herein are nanolipoprotein particles that comprise a membrane associated hydrogenase and related assemblies, devices, methods and systems.
    Type: Application
    Filed: January 12, 2009
    Publication date: July 23, 2009
    Inventors: Sarah E. Baker, Brett A. Chromy, Paul Henderson, Paul D. Hoeprich, JR.
  • Patent number: 6955915
    Abstract: A synthetic strategy for the creation of large scale chemical diversity. Solid-phase chemistry, photolabile protecting groups, and photolithography are used to achieve light-directed spatially-addressable parallel chemical synthesis. Binary masking techniques are utilized in one embodiment. A reactor system, photoremovable protecting groups, and improved data collection and handling techniques are also disclosed. A technique for screening linker molecules is also provided.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: October 18, 2005
    Assignee: Affymetrix, Inc.
    Inventors: Stephen P. A. Fodor, Lubert Stryer, Michael C. Pirrung, J. Leighton Read, Paul D. Hoeprich, Jr.
  • Patent number: 6682896
    Abstract: The present invention discloses synthetic peptides and antibodies raised thereto wherein the synthetic peptides represent important epitopic sites recognized by monoclonal antibodies which can neutralize IFN-&bgr;. Also, the uses of these peptides or antibodies thereto as diagnostics and therapeutics are disclosed.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 27, 2004
    Assignee: Schering Aktiengesellschaft
    Inventor: Paul D. Hoeprich, Jr.
  • Patent number: 6506558
    Abstract: A synthetic strategy for the creation of large scale chemical diversity. Solid-phase chemistry, photolabile protecting groups, and photolithography are used to achieve light-directed spatially-addressable parallel chemical synthesis. Binary masking techniques are utilized in one embodiment. A reactor system, photoremovable protecting groups, and improved data collection and handling techniques are also disclosed. A technique for screening linker molecules is also provided.
    Type: Grant
    Filed: November 29, 1995
    Date of Patent: January 14, 2003
    Assignee: Affymetrix Inc.
    Inventors: Stephen P. A. Fodor, Lubert Stryer, Michael C. Pirrung, J. Leighton Read, Paul D. Hoeprich, Jr.
  • Patent number: 6420169
    Abstract: A method for synthesizing oligonucleotides on a solid substrate. The method provides for the irradiation of a first predefined region of the substrate without irradiation of a second predefined region of the substrate. The irradiation step removes a protecting group therefrom. The substrate is contacted with a first nucleotide to couple the nucleotide to the substrate in the first predefined region. By repeating these steps, an array of diverse oligonucleotides is formed on the substrate.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: July 16, 2002
    Assignee: Affymetrix, Inc.
    Inventors: J. Leighton Read, Stephen P.A. Fodor, Lubert Stryer, Michael C. Pirrung, Paul D. Hoeprich, Jr.
  • Patent number: 6100043
    Abstract: Cloning systems useful for the isolation of recombinant nucleic acid are disclosed in which the recombination of cloning-system nucleic acid and foreign nucleic acid is linked to the expression of a moiety on the surface of a host organism, the moiety being a first member of a binding pair. When recombination occurs between the nucleic acid and the foreign nucleic acid, the moiety is expressed on the surface of the host organism. The isolation of recombinant nucleic acid is then performed by attaching a second member of the binding pair to a solid support and contacting the host organism with the support. When the first member of the binding pair is expressed on the surface of the host organism, the host organism binds to the second member of the binding pair attached to the solid support, thereby selectively isolating those organisms.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: August 8, 2000
    Assignee: The Perkin-Elmer Corporation
    Inventors: John A. Bridgham, John Brandis, John Leong, Paul D. Hoeprich, Jr., Charles L. Sloan, Roger A. O'Neill
  • Patent number: 6090562
    Abstract: Cloning systems useful for the isolation of recombinant nucleic acid are disclosed in which the recombination of cloning-system nucleic acid and foreign nucleic acid is linked to the expression of a moiety on the surface of a host organism, the moiety being a first member of a binding pair. When recombination occurs between the nucleic acid and the foreign nucleic acid, the moiety is expressed on the surface of the host organism. The isolation of recombinant nucleic acid is then performed by attaching a second member of the binding pair to a solid support and contacting the host organism with the support. When the first member of the binding pair is expressed on the surface of the host organism, the host organism binds to the second member of the binding pair attached to the solid support, thereby selectively isolating those organisms.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: July 18, 2000
    Assignee: The Perkin-Elmer Corporation
    Inventors: John A. Bridgham, John Brandis, John Leong, Paul D. Hoeprich, Jr., Charles L. Sloan, Roger A. O'Neill